Welcome to our dedicated page for Alerian MLP Index ETN SEC filings (Ticker: amjb), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Alerian MLP Index ETN's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Alerian MLP Index ETN's regulatory disclosures and financial reporting.
JPMorgan Chase Financial Company LLC is offering $659,000 of Uncapped Accelerated Barrier Notes linked to the S&P 500® Futures Excess Return Index, priced on February 27, 2026 with expected settlement on or about March 4, 2026.
The notes provide an Upside Leverage Factor of 1.96 on any positive Index Return and a Barrier Amount equal to 70.00% of the Initial Value (Initial Value: 557.04). If the Final Value exceeds the Initial Value, holders receive $1,000 plus the Index Return times 1.96; if the Final Value is between the Barrier Amount and Initial Value, holders receive principal; if the Final Value is below the Barrier Amount, holders incur a loss equal to the Index Return and could lose all principal.
JPMorgan Chase Financial Company LLC is offering capped dual directional buffered equity notes linked to the lesser performing of the Russell 2000® and the S&P 500®. The notes price on or about March 26, 2026 and settle on or about March 31, 2026, with maturity on April 29, 2027.
Key terms: minimum denomination $1,000; Maximum Upside Return of at least 14.00%; Buffer Amount of 10.00%. Estimated value if priced today: $964.00 per $1,000 (will not be less than $900.00). Investors can lose up to 90.00% of principal if the lesser performing index declines by more than the buffer. Payments are unsecured obligations of JPMorgan Financial, fully guaranteed by JPMorgan Chase & Co..
JPMorgan Chase Financial Company LLC priced $3,090,000 of Uncapped Buffered Return Enhanced Notes due March 2, 2029. The notes pay 1.63× any appreciation of the least performing of the Dow Jones Industrial Average®, the Russell 2000® Index and the S&P 500® Index at maturity, subject to a 10.00% buffer. Investors receive principal at maturity if losses on the least performing Index do not exceed 10.00%; if the least performing Index declines by more than 10.00%, investors lose 1% of principal for each additional 1% decline, up to a 90.00% loss. The notes priced on February 27, 2026 and are expected to settle on or about March 4, 2026, with an observation date of February 27, 2029. Payments are obligations of JPMorgan Chase Financial Company LLC and are fully and unconditionally guaranteed by JPMorgan Chase & Co.; any payments are subject to both entities' credit risk.
JPMorgan Chase Financial Company LLC priced $2,066,000 of Buffered Digital Notes linked to the least performing of the Nasdaq-100 Index, the Russell 2000 Index and the SPDR S&P Regional Banking ETF. The notes pay a Contingent Digital Return of 9.10% at maturity if the least performing underlying is down no more than the Buffer Amount of 25.00%. Pricing date was February 27, 2026, with settlement on or about March 4, 2026, an Observation Date of March 29, 2027, and Maturity Date of April 1, 2027. The notes are unsecured obligations of JPMorgan Financial and are fully and unconditionally guaranteed by JPMorgan Chase & Co., and are subject to the credit risk of both entities. Investors may lose up to 75.00% of principal if the least performing underlying declines more than the buffer. The estimated value at issuance was $986.90 per $1,000 note; price to public was $1,000 per note with selling commissions of $4 per note.
JPMorgan Chase Financial Company LLC is offering Auto Callable Contingent Interest Notes linked to the common stock of Thermo Fisher Scientific Inc. The notes are sold at $1,000 per note, with proceeds to the issuer of $990 per note and aggregate proceeds of $495,000. The notes pay a $25.00 contingent interest per $1,000 on each qualifying Review Date and may be automatically called beginning on June 11, 2026 if the Reference Stock closes at or above the Stock Strike Price ($520.12). The Interest Barrier is $418.17648 (80.40% of the Stock Strike Price). At maturity (March 16, 2027), if a Trigger Event has occurred the payment is reduced using a Downside Leverage Factor of 1.24378, causing potential loss of principal; if no Trigger Event occurs, principal plus any contingent coupon is payable.
JPMorgan Chase Financial Company LLC is offering $2,557,000 of Capped Dual Directional Buffered Equity Notes linked to the Nasdaq-100 Index®. The notes, priced on February 27, 2026 and expected to settle on or about March 4, 2026, mature on June 2, 2027 with an observation date of May 27, 2027.
The notes provide a capped upside return of 13.15% if the Index appreciates and a buffered treatment on declines up to a 15.00% Buffer Amount; if the Index falls beyond the buffer, investors lose 1% of principal for each additional 1% decline (up to an 85.00% principal loss). The CUSIP is 46660MXU4.
JPMorgan Chase Financial Company LLC priced $108,000 of Auto Callable Notes linked to the J.P. Morgan Multi-Asset Index. The notes priced on February 27, 2026 with expected settlement on March 4, 2026 and are fully and unconditionally guaranteed by JPMorgan Chase & Co.
Key terms include a Participation Rate of 100.00%, an Initial Value of 328.82, automatic call opportunities beginning on February 26, 2027 with step-up Call Premiums of $87.50, $175.00, $262.50 and $350.00 for the four pre-final Review Dates, and a maturity date of March 4, 2031.
The price to public is $1,000 per note ($108,000 aggregate), the estimated value was $960.80 per note when set, and proceeds to issuer are $992.6320 per note after commissions. The notes are unsecured obligations and subject to the credit risk of JPMorgan Financial and JPMorgan Chase & Co.; they do not pay interest and include substantial index, liquidity and model risks.
JPMorgan Chase Financial Company LLC priced $2,155,000 of Digital Barrier Notes linked to the ADRs of Novo Nordisk A/S. The notes priced on February 27, 2026 with expected settlement on or about March 4, 2026 and maturity on April 1, 2027.
The notes pay a 24.25% contingent digital return at maturity per $1,000 principal if the Final Value is greater than or equal to 70.00% of the Initial Value. The Initial Value was $37.45 on the Pricing Date and the Observation Date is March 29, 2027. If the Final Value is below the 70.00% barrier, repayment equals $1,000 plus the Stock Return and investors can lose a significant portion or all principal.
JPMorgan Chase Financial Company LLC is offering Auto Callable Dual Directional Buffered Return Enhanced Notes linked to one share of the Class A common stock of CrowdStrike Holdings, Inc. The offering totals $550,000 at a price to public of $1,000 per note.
The notes pay a 32.75% call premium if automatically called on the Review Date (March 11, 2027), provide uncapped, leveraged upside with an Upside Leverage Factor 1.50, and include a Contingent Buffer Amount 30.00% that protects up to 30% of negative stock returns. The Stock Strike Price is $381.10 (Strike Date February 26, 2026); Pricing Date is February 27, 2026; Valuation Date is February 28, 2028; Maturity Date is March 2, 2028.
The notes are unsecured obligations of JPMorgan Chase Financial Company LLC, guaranteed by JPMorgan Chase & Co., and carry issuer and guarantor credit risk. If the Final Stock Price is more than 30.00% below the Stock Strike Price at maturity, holders will lose principal on a one-for-one basis.
JPMorgan Chase Financial Company LLC is offering $1,491,000 in Review Notes linked to the MerQube US Large-Cap Vol Advantage Index, priced on February 27, 2026 with expected settlement on or about March 4, 2026.
The notes mature on March 2, 2029 and can be automatically called beginning on March 2, 2027; each automatic call pays the $1,000 principal plus a rising Call Premium Amount (first Review Date: 25.25%; final Review Date: 75.75%). The Index level reflects a 6.0% per annum daily deduction. If not called, repayment depends on the Final Value relative to a Barrier Amount equal to 75.00% of the Initial Value (Initial Value: 3,782.85); a Final Value below the Barrier exposes investors to principal loss, potentially total loss.
The notes are unsecured obligations of JPMorgan Financial, fully and unconditionally guaranteed by JPMorgan Chase & Co. Minimum denominations are $1,000; estimated value at pricing was $911.80 per $1,000 note and the price to public was $1,000 per note (selling commissions $40 per note).